Amgen (NASDAQ:AMGN) today announced financial results for the fourth quarter and full year of 2024 versus comparable ...

Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

Oprah Winfrey says taking a GLP-1 drug such as Ozempic and Wegovy has changed her entire perspective on “thin people.” A Type 2 diabetes medication that can also aid in weight loss ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat substance abuse disorders, psychosis, infections, cancer and dementia ...

Related FDA approves weight-loss drug Zepbound to treat sleep apnea FDA says shortage of GLP-1 drug tirzepatide is over Merck reaches weight-loss drug deal worth up to $2 billion with China-based ...

AUSTIN, Texas--(BUSINESS WIRE)--ImmunoPrecise Antibodies Ltd. (IPA) (NASDAQ: IPA) has developed a new class of GLP-1 therapies entirely through artificial intelligence, designed to enhance ...

“This is a trend that is here to stay.” Roughly 14% of U.S. adults have taken GLP-1 drugs to lose weight or manage other diseases like diabetes. The medications, which suppress ...

Additionally, IPA has optimized its GLP-1 alternatives for compatibility with nucleic acid-based expression systems in collaboration with Aldevron, LLC (a Danaher company). While IPA has strategically ...

This marks Heap’s first-ever entry on the Hot 100. Even though Heap herself has never had a solo hit on the chart, her songs have made waves here before. Jason Derulo sampled “Hide and Seek” ...

The streaming giant also has an industry-leading churn rate: Just 1.8% of its customers canceled last quarter, according to the streaming-data firm Antenna. This is a sign that subscribers largely ...

Competition is tightening, with Eli Lilly (NYSE:LLY) racing alongside Novo in the GLP-1 space. Novo's pipeline powerhouse, CagriSema, recently fell short of its weight-loss goals, but its ...